COBAS TAQSCREEN MPX TEST 04584244190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2012-06-20 for COBAS TAQSCREEN MPX TEST 04584244190 manufactured by Roche Molecular Systems.

Event Text Entries

[10038969] (b)(4). No product or batch non-conformance was identified. Upon investigation there was no trend found in the field. Qc release data for 077859 was reviewed and the issue of discrepant results has not been observed. There have not been any manufacturing non-conformance reports for batch 077859. Retain testing of the complaint batch 077859 was tested for this case and generated valid and acceptable results. The sample was sent for sequencing analysis and despite several attempts to obtain a (b)(4) sequence from the sample, no virus sequence was obtained. -note: the sequencing analysis may detect a viral sequence with sample that has a viral load below (b)(4) copies/ml, thus if sample is thought to contain a (b)(4) low titer, sequencing analysis may not generate a (b)(4) sequence. Testing with the cobas taqman (b)(4) test for use with the high pure system generated a result of (b)(6) for both aliquots of the sample tested. A result of (b)(6) indicates that the calculated iu/ml are below the limit of detection of the assay. Report results as (b)(4) dna detected, less than (b)(6) iu/ml. According to the cobas taqman (b)(4) test for use with the high pure system package insert. The sample was individually tested with the cobas taqscreen mpx test, v2. 0 (mpx v2. 0) and generated (b)(6) results. The limit of detection for (b)(6) with the mpx v2. 0 test is (b)(6) iu/ml ((b)(4) average lod); therefore, it is possible that the sample with a low (b)(4) titer may not be detected by the assay 100% of the time. The results generated for the donor sample at the customer site, at (b)(4), and during the case investigation indicate that the sample contains a very low (b)(4) titer that through the poisson affect was sporadically detected with the mpx test at the customer site and with the chiron test at the (b)(4). This was further supported during the investigative testing as the cobas taqman (b)(4) test for use with the high pure system generated a result that indicates (b)(4) viral presence in the sample but at a very low titer (not quantifiable by the assay). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[15098513] A customer in (b)(6) alleges that discrepant (b)(6) results were generated when using the cobas taqscreen mpx test. During a routine run with the mpx test a primary pool of 24 generated (b)(6) results. Six secondary pools of 4 were then tested and one pool generated a (b)(6) result. The donation was then tested in resolution pooling of 1 and generated negative results. The donation was then tested at (b)(6) using a competitor test (chiron). One donation was found to be not reactive (low level) and also generated (b)(6) negative serology results.
Patient Sequence No: 1, Text Type: D, B5


[15272918] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of the investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2012-00027
MDR Report Key2623238
Report Source01,05
Date Received2012-06-20
Date of Report2012-09-13
Date of Event2012-09-13
Date Mfgr Received2012-09-13
Date Added to Maude2012-10-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS TAQSCREEN MPX TEST
Generic NameHEPATITIS VIRAL B DNA DETECTION
Product CodeMKT
Date Received2012-06-20
Catalog Number04584244190
Lot Number077859
Device Expiration Date2013-09-30
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBUR NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2012-06-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.